
响应面法优化六妹羊肚菌边角料中麦角硫因的提取工艺
Optimization of extraction process of ergothioneine from Morchella sextelata scraps by response surface methodology
为提高六妹羊肚菌边角料中麦角硫因的得率,以麦角硫因得率为评价标准,分析了提取温度、乙醇浓度、液料比、提取时间等单因素对麦角硫因提取量的影响,在单因素实验的基础上通过响应面法对六妹羊肚菌边角料中麦角硫因的提取工艺条件进行了优化。单因素和响应面法得到的麦角硫因最佳提取工艺条件:液料比为40:1 (体积质量比)、乙醇浓度为50%、提取温度为60 ℃、提取时间为20 min。以该条件进行验证实验所得麦角硫因提取量为(0.236±0.000 887) mg/g,与预测值0.235 mg/g无显著差异(误差值0.426%),表明优化得到的工艺具有有效性和可靠性。本研究确定了六妹羊肚菌边角料中麦角硫因的最佳提取工艺,为六妹羊肚菌边角料的开发利用提供基础数据。
The effect of extraction temperature, ethylalcohol concentration, liquid to material ratio and extraction time on the extraction yield of ergothioneine in M. sextelata scraps were studied by using the content of ergothioneine obtained as indicator, and the response surface methodology based on single factor experiment was applied to optimize the technological process of extraction. The results obtained by single factor experiment and response surface methodology indicated that liquid to material ratio of 40:1 (mL/g), ethylalcohol concentration of 50%, extraction temperature of 60 ℃, and extraction time of 20 min were the optimum extraction condition. Under this optimized condition, the extraction yield of ergothioneine was (0.236±0.000 887) mg/g, no significantly difference was found as compared with estimated value 0.235 mg/g (error value 0.426%), indicating that the optimized process was effective and reliable. This study provides basic data for utilization of M. sextelata scraps.
六妹羊肚菌 / 边角料 / 麦角硫因 / 响应面法 / 含量测定 {{custom_keyword}} /
Morchella sextelata / scrap / ergothioneine / response surface methodology / content determination {{custom_keyword}} /
表1 qRT-PCR引物联序列Table 1 Primers’ sequences for qRT-PCR |
Gene | Forward primer (5ʹ→3ʹ) | Reverse primer (3ʹ→5ʹ) |
---|---|---|
GAPDH | CTCCTCCTGTTCGACAGTCA | CGACCAAATCCGTTGACTCC |
Claudin-1 | CACCGTCTGTGTTTGAGCA | CAAACCACCGCTTACAGATG |
Occludin | GACTATGTGGAAAGAGTTGAC | ACCGCTGCTGTAACGAG |
ZO-1 | TTCACGCAGTTACGAGCAAG | TTGGTGTTTGAAGGCAGAGC |
图1 棕榈酸和银耳多糖对Caco-2细胞活力和完整性的影响 A:不同浓度TPs对细胞活力影响;B:TPs和PAd对细胞活力影响;C:TPs和PAd对细胞完整性的影响. PAd组与CON组相比,#P<0.05,##P<0.01;Pad+TPs处理组与PAd组相比,*P<0.05,**P<0.01. 下同Fig. 1 Effects of palmitic acid (PAd) and Tremella fuciformis polysaccharides (TPs) on cell viability and TEER value of Caco-2. A: Effects of TPs concentration on cell viability; B: Effects of TPs and PAd on cell viability; C: Effects of TPs and PAd on cell integrity. PAd vs. CON, #P<0.05 and ##P<0.01; PAd+TPs treatment group vs. PAd, *P<0.05 and **P<0.01. The same below. |
图4 银耳多糖对棕榈酸诱导的紧密连接蛋白mRNA表达量的影响 A:Claudin-1水平;B:Occludin水平;C:ZO-1水平Fig. 4 Effect of TPs on PAd-induced tight junction protein mRNA expression. A: Claudin-1 level; B: Occludin level; C: ZO-1 level. |
图5 银耳多糖对棕榈酸诱导的紧密连接蛋白表达量的影响 A:Western blot检测Claudin-1、Occludin、ZO-1的蛋白条带;B:Claudin-1、Occludin、ZO-1的相对表达量Fig. 5 Effects of TPs on PAd-induced tight junction protein expression. A: Protein bands of Claudin-1, Occludin and ZO-1 were detected by Western blot. B: Relative expression of Claudin-1, Occludin, and ZO-1. |
图6 银耳多糖对TRL4/MyD88/NF-κB信号通路的影响 A:Western blot检测TLR4、MyD88、p-NF-κB的蛋白条带;B:TLR4、MyD88、p-NF-κB的相对表达量Fig. 6 Effects of TPs on TRL4/MyD88/NF-κB signaling pathway. A: Protein bands of TLR4, MyD88, and p-NF-κB were detected by Western blot. B: Relative expression of TLR4, MyD88, and p-NF-κB. |
[1] |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[2] |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[3] |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[4] |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[5] |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[6] |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[7] |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[8] |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[9] |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[10] |
More and more people have recently payed their attention to studies or investigations on medicinal fungi in China. However, many nomenclatural inconsistencies were found in the Chinese reports. The publications on Chinese medicinal fungi were critically reviewed. As a result, 473 medicinal fungi from China were enumerated in the present checklist. All of the names were checked or revised in accordance with the contemporary taxonomy and the latest version of the International Code of Botanical Nomenclature (Vienna Code). The ‘out-of-date’ names, ill-names, and un-existed names and misapplied names in the previous reports were revised. The common synonyms were listed after their valid names. The main medicinal functions of each species, together with the original or important references, were provided.
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[11] |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[12] |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[13] |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[14] |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[15] |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[16] |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[17] |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[18] |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[19] |
Ergothioneine (EGT) is one of the most representative bioactive ingredients in edible fungi. In addition to being abundant in the fruiting bodies of edible fungi, it can also be synthesized by a variety of microorganisms, including actinomycetes, fungi, certain yeasts, and archaea through various pathways. EGT has a variety of physiological activities such as antioxidant, anti-inflammatory, and immune-enhancing effects. In the food industry, EGT also shows a good color-protecting effect and food preservation function due to its free radical scavenging ability and anti-lipid peroxidation ability. In this paper, the sources, biological activities, and applications of EGT in the food industry were reviewed to provide references for further research and application of EGT in the future.
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[20] |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[21] |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[22] |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[23] |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[24] |
While mushrooms are the highest dietary source for the unique sulfur-containing antioxidant ergothioneine, little is known regarding levels of the major biological antioxidant glutathione. Thus, our objectives were to determine and compare levels of glutathione, as well as ergothioneine, in different species of mushrooms. Glutathione levels varied >20-fold (0.11-2.41mg/gdw) with some varieties having higher levels than reported for other foods. Ergothioneine levels also varied widely (0.15-7.27mg/gdw) and were highly correlated with those of glutathione (r=0.62, P<0.001). Both antioxidants were more concentrated in pileus than stipe tissues in selected mushrooms species. Agaricus bisporus harvested during the third cropping flush contained higher levels of ergothioneine and glutathione compared to the first flush, possibly as a response to increased oxidative stress. This study demonstrated that certain mushroom species are high in glutathione and ergothioneine and should be considered an excellent dietary source of these important antioxidants.Copyright © 2017 Elsevier Ltd. All rights reserved.
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[25] |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[26] |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[27] |
Ergothioneine (ET) is a naturally occurring antioxidant that is synthesized by non-yeast fungi and certain bacteria. ET is not synthesized by animals, including humans, but is avidly taken up from the diet, especially from mushrooms. In the current study, we elucidated the effect of ET on the hCMEC/D3 human brain endothelial cell line. Endothelial cells are exposed to high levels of the cholesterol oxidation product, 7-ketocholesterol (7KC), in patients with cardiovascular disease and diabetes, and this process is thought to mediate pathological inflammation. 7KC induces a dose-dependent loss of cell viability and an increase in apoptosis and necrosis in the endothelial cells. A relocalization of the tight junction proteins, zonula occludens-1 (ZO-1) and claudin-5, towards the nucleus of the cells was also observed. These effects were significantly attenuated by ET. In addition, 7KC induces marked increases in the mRNA expression of pro-inflammatory cytokines, IL-1β IL-6, IL-8, TNF-α and cyclooxygenase-2 (COX2), as well as COX2 enzymatic activity, and these were significantly reduced by ET. Moreover, the cytoprotective and anti-inflammatory effects of ET were significantly reduced by co-incubation with an inhibitor of the ET transporter, OCTN1 (VHCL). This shows that ET needs to enter the endothelial cells to have a protective effect and is unlikely to act via extracellular neutralizing of 7KC. The protective effect on inflammation in brain endothelial cells suggests that ET might be useful as a nutraceutical for the prevention or management of neurovascular diseases, such as stroke and vascular dementia. Moreover, the ability of ET to cross the blood-brain barrier could point to its usefulness in combatting 7KC that is produced in the CNS during neuroinflammation, e.g. after excitotoxicity, in chronic neurodegenerative diseases, and possibly COVID-19-related neurologic complications.
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[28] |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[29] |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[30] |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[31] |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[32] |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[33] |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[34] |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[35] |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[36] |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[37] |
The hepatoprotective activity of cultured mycelium of morel mushroom Morchella esculenta against CCl(4) and ethanol induced chronic hepatotoxicity was investigated. Hepatotoxicity was induced by challenging the animals with CCl(4) (1:5, v/v, 3.75 ml/kg body weight, i.p., 30 doses) and ethanol (36%, v/v, 6 ml/animal, p.o., 35 doses) and the extract was administered at two concentrations (250 and 500 mg/kg body weight). Hepatoprotection was evaluated by determining the activities of liver function marker enzymes and antioxidant status of liver and also by histopathological observations of liver tissue. Administration of both ethanol and CCl(4) elevated the levels of liver function enzymes, GOT, GPT and ALP in serum drastically. The treatment with the extract decreased the elevated serum GOT, GPT and ALP activities in a dose dependent manner. The extract also restored the depleted levels of antioxidants in liver consequent to CCl(4) and ethanol challenge. The results indicated that aqueous-ethanolic extract of M. esculenta mycelium possessed significant hepatoprotective activity. The conclusion is also supported by the biochemical determinations and histopathological observations. The findings thus suggest the potential therapeutic use of morel mushroom mycelium as a novel hepatoprotective agent.Copyright © 2011 Elsevier GmbH. All rights reserved.
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[38] |
Morchella esculenta (L) Pers. is an excellently edible and delicious morel mushroom found growing in the temperate forests. The mycelium of this mushroom is widely used as a flavouring agent. The current investigation was undertaken to explore the protective effect of the aqueous-ethanol extract of cultured mycelium of M. esculenta against cisplatin and gentamicin induced acute renal toxicity in Swiss albino mice. Cisplatin and gentamicin when administered induced a marked renal failure, characterized by a significant increase in serum urea and creatinine concentrations. Treatment with the extract at 250 and 500mg/kg body weight decreased the cisplatin and gentamicin induced increase in serum creatinine and urea levels. Treatment with the extract also restored the depleted antioxidant defense system. The decreased activity of superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), and reduced glutathione (GSH) in the kidneys consequent to cisplatin and gentamicin administration was significantly elevated. The enhanced renal antioxidant defense system also prevented the tissue lipid peroxidation. The experimental results suggest that aqueous-ethanol extract of morel mushroom, M. esculenta mycelium protected cisplatin and gentamicin induced nephrotoxicity possibly by enhancing renal antioxidant system. The findings thus suggest the potential therapeutic use of morel mushroom mycelium as a novel nephroprotective agent.
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[39] |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[40] |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[41] |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[42] |
We recently identified a health conscious food pattern (HCFP) associated with reduced risk of cardiometabolic disease. However, the molecular events linking the healthy food pattern to reduced risk of cardiometabolic disease are unknown. Our aim was to identify plasma metabolites associated with the HCFP and test if such metabolites predict cardiometabolic disease and mortality.Using liquid-chromatography mass-spectrometry, 112 plasma metabolites were measured in 3236 participants without cardiovascular disease (CVD) and diabetes mellitus from the population-based Malmö Diet and Cancer study. Metabolites associated with the HCFP were identified using multivariable adjusted linear regressions followed by Bonferroni correction. The healthy dietary biomarkers were subsequently related to risk of cardiometabolic disease and mortality during long-term follow-up with multivariable adjusted Cox proportional hazards models.During a median follow-up time of 21.4 years, 603 participants developed CVD, 362 developed diabetes mellitus and 843 participants died. Five healthy dietary biomarkers were associated with the HCFP at baseline (p<0.0004) and four predicted at least one of the studied end points (p<0.05). Ergothioneine was the metabolite most strongly connected to the HCFP and was associated with a lower risk of coronary disease (HR per 1 SD increment of ergothioneine, HR=0.85, p=0.01), cardiovascular mortality (HR=0.79, p=0.002) and overall mortality (HR=0.86, p=4e-5).We identified that higher ergothioneine was an independent marker of lower risk of cardiometabolic disease and mortality, which potentially can be induced by a specific healthy dietary intake.© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[43] |
Polysaccharides extracted from Morchella angusticepes Peck (PMEP) were chemically modified to obtain sulfated, carboxymethylated, and acetyled derivatives. Results showed that the acetyled derivatives with the degree of substitution (0.40 ± 0.07) exerted higher antioxidant ability than native polysaccharides, demonstrating inhibitory effects on growth of human hepatoma cells (EC = 0.710 ± 0.002 mg/mL) and human colon cancer cells (EC = 1.229 ± 0.008 mg/mL). It indicated that the acetylation was a favorable way to enhance the bioactivities of PMEP. PRACTICAL APPLICATION: Polysaccharides extracted from Morchella angusticepes Peck (PMEP) have many health-promoting properties. Chemical modifications could improve the bioactivities of polysaccharides. We demonstrated that acetylation enhanced the cellular antioxidant and antiproliferative activities of PMEP. The results support further research that explores clinical utility, and may justify ex vivo and in vivo designs toward that end.© 2019 Institute of Food Technologists®.
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[44] |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[45] |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[46] |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[47] |
Morels are edible mushrooms appreciated worldwide for their savory flavor. Morels have been in use in traditional medicine for centuries, due to their health-related benefits, and current research demonstrated their anti-oxidative and anti-inflammatory bioactivities, in addition to immunostimulatory and anti-tumor properties. In spite of the high demand for morels and their increasing economic importance, their cultivation is limited, and they are either used as wild harvested or fermented in culture, for consumption as a functional food and for food-flavoring. Morel's health benefits were attributed mainly to polysaccharides as the active compounds, and to various phytochemicals, mainly phenolic compounds, tocopherols, ascorbic acid and vitamin D. Morel's nutritional composition was reported, including sugar, amino acid, fatty and organic acid and mineral profile. Information regarding Morel's flavor is limited, and while some of their taste attributes have been described, including the role of umami taste, details about their volatile aroma profile are scarce, and it was reported to include eight carbon volatiles, the main aroma volatiles typical to most mushrooms. To the best of our knowledge, this is the first review presenting morels' nutritional and phytochemical composition, health benefits and flavor, and we will review the available information in current literature regarding these aspects in light of morels phenotypic plasticity.
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[48] |
Ergothioneine is a biologically important compound that has been shown to be transported by the organic cation transporter novel type 1 (OCTN1). Following this discovery, a variety of alternate functions for OCTN1 have been suggested including an integral function in the extra-neuronal cholinergic system. The present study reaffirms the primacy of ergothioneine over these alternate substrates using natively expressed OCTN1 in HeLa cells. Besides the general transport inhibitors, quinidine, verapamil and pyrilamine no other putative substrate inhibited ergothioneine transport significantly, with only a slight inhibition demonstrated by carnitine. Even compounds structurally similar to ergothioneine failed to inhibit ergothioneine uptake, suggesting high selectivity of OCTN1. Ergothioneine was found to be avidly accumulated even at low concentrations (300 nM) by HeLa cells.Copyright © 2019 Elsevier Inc. All rights reserved.
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[49] |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[50] |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[51] |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[52] |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[53] |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[54] |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[55] |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[56] |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[57] |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[58] |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[59] |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[60] |
曹亮, 2020. 羊肚菌多糖对小鼠抗运动疲劳及耐缺氧的影响. 中国食用菌, 39(6): 40-42
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[61] |
戴玉成, 杨祝良, 2008. 中国药用真菌名录及部分名称的修订. 菌物学报, 27: 801-824
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[62] |
鄂恒超, 冯路路, 赵晓燕, 李晓贝, 赵志勇, 何香伟, 张艳梅, 2022. 超高效液相色谱法测定食用菌中L-麦角硫因及质谱确证. 分析试验室, 41(5): 529-534
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[63] |
范三红, 任嘉兴, 张锦华, 金晓弟, 白宝清, 2019. 响应面优化羊肚菌多糖提取工艺及抗氧化性. 食品工业科技, 40(6): 179-185, 192
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[64] |
冯路路, 鄂恒超, 张艳梅, 李晓贝, 周昌艳, 赵晓燕, 任佳丽, 2021. 食用菌中麦角硫因提取分离和检测方法研究进展. 食用菌学报, 28(1): 115-123
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[65] |
何鑫怡, 周子艺, 陈媛媛, 赵吉春, 李富华, 明建, 2023. 麦角硫因生物活性及其在食品工业中的应用. 食品与发酵工业, 49(10): 285-292
麦角硫因(ergothioneine, EGT)是食用菌最具代表性的生物活性成分之一。除了广泛存在于食用菌子实体,还可以由多种微生物,包括放线菌、真菌、某些酵母菌和古细菌通过需氧或厌氧途径合成。EGT具有抗氧化、抗炎和提高免疫等多种生理活性。在食品工业中,基于其自由基清除能力和抗脂质过氧化能力,EGT还表现出了良好的护色效果和食品保藏功能。论文综述了EGT的来源、生物活性和在食品工业中的应用,旨在为EGT今后的进一步研究和应用提供参考。
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[66] |
胡晶晶, 张怡馨, 王艳, 莫宇丽, 王杰, 2019. 响应面法优化金针菇麦角硫因的提取工艺. 食品工业科技, 40(9): 171-177
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[67] |
黄瑶, 2019. 羊肚菌多糖(ME-X)结构鉴定、生物活性及抗肿瘤机制的研究. 西华师范大学硕士论文, 南充. 1-78
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[68] |
李井雷, 刘玉婷, 宗帅, 张家奇, 叶明, 2020. 羊肚菌胞外多糖体外降血糖降血脂活性研究. 食品研究与开发, 41(16): 39-45
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[69] |
李亚欢, 2016. 杏鲍菇中麦角硫因的提取纯化和抗氧化活性研究. 华南农业大学硕士论文, 广州. 1-73
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[70] |
李娅丽, 张越非, 刘哲, 刘迪, 池汝安, 2015. 响应曲面法优化人参皂苷及多糖微波辅助提取工艺. 中国医药导报, 12(16): 42-47
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[71] |
莫宇丽, 李亚欢, 王艳, 胡晶晶, 张怡馨, 王杰, 2020. 响应面法优化超声微波联合提取杏鲍菇中麦角硫因工艺. 食品工业科技, 41(1): 143-149
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[72] |
木开代斯·买合木提, 2023. 黑牛肝菌麦角硫因的分离纯化及抑制B16F10细胞黑色素生成的转录组学研究. 仲恺农业工程学院硕士论文, 广州. 1-69
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[73] |
潘虹余, 郭丽琼, 林俊芳, 2019. 麦角硫因机体内的分布与代谢和其在疾病中的作用研究进展. 食品科学, 40(23): 334-340
麦角硫因是一种稀有的天然氨基酸类强抗氧化剂,由放线菌、蓝细菌、部分真菌(例如链霉菌、分枝杆菌等)和蘑菇等微生物合成。动物(包括人类)和植物自身不能在体内合成麦角硫因,植物可通过根系从土壤中吸收微生物合成的麦角硫因,而动物可从食物中吸收和积累麦角硫因。人体通过有机阳离子转运蛋白1型从食物中吸收麦角硫因,其广泛分布于人体的细胞和组织中。已有大量研究报道了麦角硫因的合成、自然界中的分布、化学性质、生理功能和其作为抗氧化剂的特性。尽管研究证明麦角硫因在体外具有明显的抗氧化活性和细胞保护作用,但对其在体内的生理功能研究仍有限。本文旨在综述麦角硫因的独特性质、生物合成以及预防疾病的潜力。
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[74] |
田金凤, 尚远宏, 肖宗妮, 2024. 羊肚菌的营养成分、功能和加工的研究进展. 食品工业科技, 45(9): 419-428
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[75] |
万安露, 2019. 五种牛肝菌中麦角硫因对四氯化碳致小鼠肝损伤的保护作用. 昆明理工大学硕士论文, 昆明. 1-86
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[76] |
王艳辉, 闫林林, 李俊仁, 郑光耀, 2023. 响应面法优化大球盖菇麦角硫因的提取工艺及其体外抗氧化能力稳定性的考察. 食品安全质量检测学报, 14(16): 293-302
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[77] |
徐鸿雁, 谢占玲, 孟清, 马德娟, 孙灵芝, 2022. 镉胁迫小海绵羊肚菌氧化损伤及其抗氧化防御. 菌物学报, 41(4): 668-679
羊肚菌Morchella是全球广泛分布的食药用真菌,重金属镉(Cd)在羊肚菌中的积累受到越来越多的关注。然而,羊肚菌镉积累的机理尚不清楚。本研究通过在0-5.0 mg/L Cd浓度环境中培养小海绵羊肚菌Morchella spongiola,测定Cd胁迫下其菌丝生长速率、丙二醛(MDA)、过氧化氢(H<sub>2</sub>O<sub>2</sub>)、超氧化物歧化酶(SOD)、过氧化物酶(POD)、过氧化氢酶(CAT)、谷胱甘肽过氧化物酶(GSH-Px)、谷胱甘肽(GSH)、抗坏血酸(ASA)及细胞Cd积累量等生理生化指标,旨在明晰小海绵羊肚菌响应Cd毒害的抗氧化防御响应机理。结果表明随着Cd浓度的增加,小海绵羊肚菌菌丝生长呈现出“升-降-升-降”的双峰响应变化,其中0.15、0.90和1.50 mg/L为菌丝生长Cd浓度关键拐点。Cd胁迫导致的氧化损伤与其初始浓度呈现正相关,胁迫3 d时MDA和H<sub>2</sub>O<sub>2</sub>含量显示出较大提升,5.0 mg/L处理组MDA和H<sub>2</sub>O<sub>2</sub>含量比对照组分别高出5.80倍和6.08倍。胁迫浓度、胁迫时间对抗氧化系统的影响各异,SOD、POD活性随浓度增大而逐渐升高,在1.5-5.0 mg/L浓度范围内,SOD和POD酶活性分别增加了1.96倍和2.15倍;CAT和GSH-Px酶活在0.15 mg/L时达到最大值,之后增加Cd浓度酶活性被抑制;GSH和ASA含量在Cd胁迫初期呈浓度依赖性增加,胁迫5 d后表现二者含量先升高后降低。此外,小海绵羊肚菌胞外Cd积累量随着外源Cd浓度的提高而增加,而胞内Cd含量在浓度为1.5-5.0 mg/L范围内无明显增加。本研究首次系统研究了小海绵羊肚菌响应Cd胁迫浓度、胁迫时间的动态趋势与内在变化规律,不仅为羊肚菌与重金属相互作用关系研究奠定基础,也为羊肚菌用于Cd污染废水生物修复提供了理论依据。
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[78] |
薛莉, 2014. 羊肚菌胞外粗多糖对S180肉瘤小鼠的抑制实验. 山西中医学院学报, 15(2): 27-29
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[79] |
杨辉, 闫明明, 2012. 果胶酶提取大枣多糖的工艺研究. 陕西科技大学学报, 30(5): 62-66
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[80] |
张翠, 赵艳敏, 白淑芳, 刘岱琳, 2013. HPLC法测定不同品种蘑菇中麦角硫因的含量. 食品工业科技, 34(23): 307-310
{{custom_citation.content}}
{{custom_citation.annotation}}
|
[81] |
赵艳敏, 雷智东, 刘成航, 刘岱琳, 2016. 高效液相色谱法测定多种真菌中麦角硫因含量. 食品研究与开发, 37(2): 117-119
{{custom_citation.content}}
{{custom_citation.annotation}}
|
{{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
〈 |
|
〉 |